Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00407303
Status:
COMPLETED
Last Update Posted:
2016-07-21
First Post:
2006-12-01
Brief Title:
Safety and Efficacy of Obatoclax Mesylate GX15-070MS in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma MCL
Sponsor:
Organization:
Teva Branded Pharmaceutical Products RD Inc